News - Page 97 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article PsyBio Therapeutics Announces Expansion of Patent Portfolio with Additional Global Patent Applications

PsyBio Therapeutics Announces Expansion of Patent Portfolio with Additional Global Patent Applications

Post published:August 9, 2022
Post category:Press Release

Read more about the article Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient Advocate Thomas Hartle

Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient Advocate Thomas Hartle

Post published:August 9, 2022
Post category:Press Release

Read more about the article Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ET

Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ET

Post published:August 8, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin #113 – Analysis of Company Spending Trends; Morgan Stanley Opine on Psychedelics; COMPASS Rallies

Psychedelic Bulletin #113 – Analysis of Company Spending Trends; Morgan Stanley Opine on Psychedelics; COMPASS Rallies

Post published:August 6, 2022
Post category:Psychedelic Bulletin

Read more about the article MindMed Board of Directors Approves Reverse Share Split

MindMed Board of Directors Approves Reverse Share Split

Post published:August 5, 2022
Post category:Press Release

Read more about the article COMPASS Pathways plc announces second quarter 2022 financial results and business highlights

COMPASS Pathways plc announces second quarter 2022 financial results and business highlights

Post published:August 4, 2022
Post category:Press Release

Read more about the article MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Post published:August 4, 2022
Post category:Press Release

Read more about the article Canadian Patent Grant Strengthens Small Pharma’s International Position

Canadian Patent Grant Strengthens Small Pharma’s International Position

Post published:August 4, 2022
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough Study Data at 9th American Cough Conference

Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough Study Data at 9th American Cough Conference

Post published:August 3, 2022
Post category:Press Release

Read more about the article Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.

Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.

Post published:August 3, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.